Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Salvatore Sciacchitano, Luca Lavra, Alessandra Ulivieri, Fiorenza Magi, Gian Paolo De Francesco, Carlo Bellotti, Leila B. Salehi, Maria Trovato, Carlo Drago, Armando Bartolazzi
Published Apr 19, 2017 · Vol. 8, No. 30 · pp. 49421-49442
Bigang Liu, Shuai Gong, Qiuhui Li, Xin Chen, John Moore, Mahipal V. Suraneni, Mark D. Badeaux, Collene R. Jeter, Jianjun Shen, Rashid Mehmood, Qingxia Fan, Dean G. Tang
Published Apr 18, 2017 · Vol. 8, No. 32 · pp. 52746-52760
Erik N. Taylor, Yao Ding, Shan Zhu, Eric Cheah, Phillip Alexander, Leon Lin, George E. Aninwene II, Matthew P. Hoffman, Anita Mahajan, Abdallah S.R. Mohamed, Nathan McDannold, Clifton D. Fuller, Clark C. Chen, Richard J. Gilbert
Published Mar 16, 2017 · Vol. 8, No. 26 · pp. 41815-41826
